Supplementary
: Evidence for reported AITD non-HLA susceptibility loci. Genotype signal intensity cluster plots have been examined visually. Note that the AITD locus SCGB3A2/5q32 was not included on the ImmunoChip. Hashimoto's thyroiditis (HT), Graves' disease (GD), minor allele frequency (MAF), odds ratio (OR) and confidence interval (CI). (Table 1) and 5 (Table S1 )] independent tests, the adjusted P-value was 3.85x10 −3 for the 0.05 level of significance based on a Bonferroni correction for multiple testing. Table S2 : A summary of SNPs that show large allele frequency differences (P < 1.12x10 −6 ) between controls from the 12 geographical regions of Great Britain (Materials and Methods). Genotype signal intensity cluster plots have been examined visually for these highly differential SNPs (two SNPs were dropped rs2310187/2q12.1 and rs12210050/6p25.3). We note that the most significant LCT SNP, rs2236783/2q21.3 (P = 1.41x10 −5 ), was above the threshold P-value. Positions are in NCBI build 36 co-ordinates. distance in base pairs (dist). Figure S1 : Single-locus 1-df Cochran-Armitage trend test results at the recently reported novel AITD susceptibility locus 6q27 (1) . The most disease associated SNP, imm−6−167338101 (P = 1.6x10 −7 in HT and GD patients/controls; Table 1 ), was located within FGFR10P. The top panel -GD patients and controls; the middle panel -HT patients and controls; and, the bottom panel -GD and HT patients and controls. Figure S2: Single-locus 1-df Cochran-Armitage trend test results at the novel AITD susceptibility locus 1q36.32. The most disease associated SNP, rs2843403 (P = 7.9x10 −7 in GD patients/controls; Table 1 ), was located within MMEL1. The top panel -GD patients and controls; the middle panel -HT patients and controls; and, the bottom panel -GD and HT patients and controls. Figure S3: Single-locus 1-df Cochran-Armitage trend test results at the novel AITD susceptibility locus 3q27.3/3q28. The most disease associated SNP, rs13093110 (P = 3.7x10 −8 in HT and GD patients/controls; Table 1 ), was located within LPP. The top panel -GD patients and controls; the middle panel -HT patients and controls; and, the bottom panel -GD and HT patients and controls. 
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